Robert Andrew Heald

USPTO Granted Patents = 43 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 21 (Patent Applications = 21)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 288(Granted Patents)

Location History:

Essex, GB (2015)
Harlow, GB (2011 - 2019)
Harlow Essex, GB (2013 - 2019)
Sawbridgeworth, GB (2017 - 2023)

Company Filing History:

Chiesi Farmaceutici S.p.a.

patents

4 out of 168

F. Hoffmann-la Roche Ag

5. 1 out of 832,680

Other

patents

Years Active: 2011-2023

Loading Chart...

43 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11760753 - Benzoxazepin oxazolidinone compounds and methods of use (2023-09-19),

2. 10851091 - Benzoxazepin oxazolidinone compounds and methods of use (2020-12-01),

3. 10435414 - Tricyclic PI3K inhibitor compounds and methods of use (2019-10-08),

4. 10172830 - Pyrazolone compounds having human neutrophil elastase inhibitory properties (2019-01-08),

5. 10112932 - Benzoxazepin oxazolidinone compounds and methods of use (2018-10-30),

6. 10065970 - Tricyclic PI3K inhibitor compounds and methods of use (2018-09-04),

7. 10023558 - Compounds (2018-07-17),

8. 9951064 - Azaindazole compounds as inhibitors of T790M containing EGFR mutants (2018-04-24),

9. 9890152 - Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants (2018-02-13),

10. 9868740 - Pyrimidinone compounds which are HNE inhibitors (2018-01-16),

11. 9828382 - Pyrimidinone compounds as human neutrophil elastase inhibitors (2017-11-28),

12. 9802919 - Compounds (2017-10-31),

13. 9670228 - Benzoxazepin PI3K inhibitor compounds and methods of use (2017-06-06),

14. 9650393 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-16),

15. 9643980 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-09),

Title: The Inventive Mind of Robert Andrew Heald

Introduction:

Robert Andrew Heald is a prolific inventor hailing from Harlow, GB, with an impressive 43 patents to his name. His innovative spirit has led to groundbreaking discoveries in various fields.

Latest Patents:

One of Heald's latest patents includes the development of Benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity. These compounds, with the Formula I structure, showcase Heald's expertise in molecular chemistry and pharmaceutical research.

Career Highlights:

Throughout his career, Heald has made significant contributions while working at prestigious companies such as Genentech, Inc. and Chiesi Farmaceutici S.p.a. His work has undoubtedly influenced the pharmaceutical industry and paved the way for new treatment modalities.

Collaborations:

Heald has collaborated with esteemed professionals in the field, including coworkers Steven T Staben and Stephen Colin Price. Together, they have engaged in innovative projects that have pushed the boundaries of scientific knowledge and application.

Conclusion:

In conclusion, Robert Andrew Heald stands as a beacon of innovation in the world of patents and inventions. His dedication to scientific advancement and his remarkable portfolio of patents solidify his position as a key figure in the realm of research and development.

This text is generated by artificial intelligence and may not be accurate.